• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一系列肺癌患者中某些肿瘤标志物的意义]

[Significance of certain neoplastic markers in a series of patients with lung cancer].

作者信息

Cunietti E, Locatelli E, Vaiani G, Baggio E, Gandini M C, Gandini R, Fasoli A

出版信息

Minerva Med. 1984 Apr 28;75(18):1041-6.

PMID:6328365
Abstract

Perchloric acid soluble proteins (PPS) and their content of N-acetylneuraminic acid (NANA) may serve as valuable tumor markers for a variety of malignant neoplasms. To evaluate their clinical significance, PPS, NANA and carcino-embryonic antigen (CEA) were measured in 32 patients with lung cancer. High PPS (greater than or equal to 0,73 mg/ml) and NANA (greater than or equal to 96 micrograms/ml) levels occurred in 8 of 50 (16%) healthy volunteers and respectively in 22% and 54% of patients. CEA levels were high (greater than or equal to 3 ng/ml) in 1 out of 21 (5%) healthy volunteers and in 83% of the patients; 84% of the patients showed an elevation of NANA and of CEA. The highest values of the three markers seem to be associated with extensive disease but no statistically significant difference has emerged from the comparison of patients with limited disease with the ones with extensive involvement. Changes of the tumor mass correlate with changes of serum levels of PPS, NANA and CEA. It is concluded that CEA determination is clinically valuable in lung cancer, while PPS and NANA do not provide greater information.

摘要

高氯酸可溶性蛋白(PPS)及其N - 乙酰神经氨酸(NANA)含量可能是多种恶性肿瘤有价值的肿瘤标志物。为评估其临床意义,对32例肺癌患者测定了PPS、NANA和癌胚抗原(CEA)。50名健康志愿者中有8名(16%)PPS水平高(大于或等于0.73mg/ml),NANA水平高(大于或等于96μg/ml)的分别占22%和54%。21名健康志愿者中有1名(5%)CEA水平高(大于或等于3ng/ml),患者中则为83%;84%的患者NANA和CEA升高。三种标志物的最高值似乎与广泛病变有关,但局限期患者与广泛受累患者比较未发现统计学显著差异。肿瘤肿块的变化与血清PPS、NANA和CEA水平的变化相关。结论是,CEA测定在肺癌临床中有价值,而PPS和NANA未提供更多信息。

相似文献

1
[Significance of certain neoplastic markers in a series of patients with lung cancer].[一系列肺癌患者中某些肿瘤标志物的意义]
Minerva Med. 1984 Apr 28;75(18):1041-6.
2
[Clinical significance of CEA levels in lung cancer].[癌胚抗原水平在肺癌中的临床意义]
Gan No Rinsho. 1985 May;31(6 Suppl):616-22.
3
[Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].[唾液酸和癌胚抗原(CEA)作为结肠癌标志物:初步报告]
Pol Tyg Lek. 1991;46(45-47):890-1.
4
[Diagnostic value of biochemical tumor markers in brain tumors. Review of the literature and own experience with serum analysis of sialic acid (NANA), carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE)].[生化肿瘤标志物在脑肿瘤中的诊断价值。文献综述及自身对血清唾液酸(NANA)、癌胚抗原(CEA)和神经元特异性烯醇化酶(NSE)分析的经验]
Zentralbl Neurochir. 1990;51(3):129-37.
5
Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.评估手术切除的临床I期非小细胞肺癌患者血清癌胚抗原水平与治疗结果之间的关系。
Anticancer Res. 2000 May-Jun;20(3B):2177-80.
6
Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.接受放射治疗的癌症患者的血清唾液酸(TSA/LSA)和癌胚抗原(CEA)水平。
Anticancer Res. 1992 Jan-Feb;12(1):251-5.
7
Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.肺癌患者血清癌胚抗原、唾液酸和磷酸己糖异构酶水平的比较。
Neoplasma. 1995;42(5):271-4.
8
Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.七种肿瘤标志物的最佳组合在非小细胞肺癌患者首次检查时对晚期阶段的预测作用
Anticancer Res. 2001 Jul-Aug;21(4B):3085-92.
9
[Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].[细胞角蛋白19信使核糖核酸、癌胚抗原、神经元特异性烯醇化酶及组织多肽抗原联合检测在肺癌患者外周血中的意义]
Ai Zheng. 2002 Feb;21(2):196-9.
10
Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.血清肿瘤标志物CYFRA 21.1、癌胚抗原(CEA)和鳞状细胞癌抗原(SCC)在肺鳞状细胞癌中的应用。
J Exp Clin Cancer Res. 2000 Dec;19(4):477-81.